Marksans Pharma Unveils Ambitious Growth Strategy: $300M US Order Book and INR 5,000 Crore Revenue Target

Marksans Pharma has outlined strategic growth objectives, including a $300 million US order book target within the next couple of years and a revenue goal of INR 5,000 crores in 5-7 years. The company aims to achieve EBITDA margins of 19-20% or higher by FY26 and expects improvement in its UK business performance in Q3 FY26 compared to Q2 FY26.